User:Pierre Rossignol/Sandbox
From Proteopedia
(Difference between revisions)
| Line 36: | Line 36: | ||
== Disease == | == Disease == | ||
| - | In humans, patients with a high level of cysteine and glutathione-cysteine mixed with disulphide are most likely to suffer from Hallervorden-Spatz (HS) | + | In humans, patients with a high level of cysteine and glutathione-cysteine mixed with disulphide are most likely to suffer from [https://en.wikipedia.org/wiki/Pantothenate_kinase-associated_neurodegeneration Hallervorden-Spatz (HS) syndrome] which is essentially characterised by neurochemical abnormalities since it affects the [https://en.wikipedia.org/wiki/Globus_pallidus globus pallidus]. |
Patients suffering from this disease have been observed to have a low level in cysteine dioxygenase activity. | Patients suffering from this disease have been observed to have a low level in cysteine dioxygenase activity. | ||
| - | Thus, in this case, cysteine accumulates locally in the globus palladus and the conversion of cysteine to | + | Thus, in this case, cysteine accumulates locally in the globus palladus and the conversion of cysteine to [https://en.wikipedia.org/wiki/Taurine taurine] is blocked due to enzymatic inactivity. |
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
An increasing amount of cysteine may increase the level of iron content in Hallervorden-Spatz disease and the additive effects of an accumulated amount of cysteine and of ferrous iron may give rise to the formation of free radicals that can damage neuronal membranes to cause the typical morphological changes observed in this disorder. <ref> https://www.ncbi.nlm.nih.gov/pubmed/4073841 </ref> | An increasing amount of cysteine may increase the level of iron content in Hallervorden-Spatz disease and the additive effects of an accumulated amount of cysteine and of ferrous iron may give rise to the formation of free radicals that can damage neuronal membranes to cause the typical morphological changes observed in this disorder. <ref> https://www.ncbi.nlm.nih.gov/pubmed/4073841 </ref> | ||
Revision as of 12:32, 26 January 2017
Thiol dioxygenase from Pseudomonas aeruginosa
| |||||||||||
References
- ↑ https://www.ncbi.nlm.nih.gov/pubmed/21450006
- ↑ https://www.ncbi.nlm.nih.gov/pubmed/26272617
- ↑ https://www.ncbi.nlm.nih.gov/pubmed/26272617
- ↑ https://www.ncbi.nlm.nih.gov/pubmed/26272617
- ↑ https://www.ncbi.nlm.nih.gov/pubmed/26272617
- ↑ https://www.ncbi.nlm.nih.gov/pubmed/26272617
- ↑ https://www.ncbi.nlm.nih.gov/pubmed/26272617
- ↑ https://www.ncbi.nlm.nih.gov/pubmed/4073841
- ↑ https://www-ncbi-nlm-nih-gov.scd-rproxy.u-strasbg.fr/pmc/articles/PMC3136866/
- ↑ https://www.ncbi.nlm.nih.gov/Structure/mmdb/mmdbsrv.cgi?uid=130072&dps=1
- ↑ http://www.uniprot.org/uniprot/Q9I0N5
- ↑ http://www.ebi.ac.uk/interpro/protein/Q9I0N5
